Table 3 The clinicopathological characteristics of the molecular subtypes
Case No | IHC subtype | Molecular subtype | Basal-like marker | Ki67 index (%) | PR (%) | ER (%) | Grade | P53 | Immune score | TILs | PAM50 recurrence risk | Recurrence/metastasis |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Lum B | basal | positive | 80 | 0 | 1 | 3 | P | strong | high | high | Yes/m |
2 | Lum B | basal | positive | 60 | 30 | 2 | 3 | P | strong | high | med | no |
3 | Lum B | basal | positive | 60 | 0 | 1 | 2 | P | weak | 1ow | med | no |
4 | Lum B | basal | positive | 60 | 5 | 0 | 2 | N | strong | high | high | Yes/m |
5 | Lum B | basal | positive | 90 | 0 | 10 | 3 | P | weak | 1ow | high | no |
6 | Lum B | basal | positive | 40 | 10 | 5 | 3 | P | strong | high | high | Yes/m |
7 | Lum B | Lum A | positive | 30 | 90 | 90 | 2 | N | weak | 1ow | med | no |
8 | LumA | Lum A | positive | 6 | 60 | 80 | 2 | N | weak | 1ow | low | Yes/m |
9 | Lum B | Lum A | positive | 10 | 0 | 95 | 1 | N | weak | 1ow | med | no |
10 | Lum B | Lum B | positive | 20 | 95 | 95 | 2 | N | weak | 1ow | med | no |
11 | LumA | Lum A | positive | 3 | 100 | 100 | 1 | P | weak | 1ow | low | no |
12 | LumA | Lum A | positive | 10 | 30 | 60 | 1 | N | weak | 1ow | low | Yes/m |